

Spring 2020 (Volume 50, Number 1) Fall 2019 (Volume 49, Number 2) Spring 2019 (Volume 49, Number 1) Fall 2018 (Volume 48, Number 2) Spring 2018 (Volume 48, Number 1) Fall 2017 (Volume 47, Number 2) Spring 2017 (Volume 47, Number 1) Fall 2016 (Volume 46, Number 2) Spring 2016 (Volume 46, Number 1) Fall 2015 (Volume 45, Number 2) Spring 2015 (Volume 45, Number 1) Fall 2014 (Volume 44, Number 2) Spring 2014 (Volume 44, Number 1) Fall 2013 (Volume 43, Number 2) Spring 2013 (Volume 43, Number 1) Fall 2012 (Volume 42, Number 2) Spring 2012 (Volume 42, Number 1) Fall 2011 (Volume 41, Number 2) Spring 2011 (Volume 41, Number 1) Fall 2010 (Volume 40, Number 2) Spring 2010 (Volume 40, Number 1) Fall 2009 (Volume 39, Number 2) Spring 2009 (Volume 39, Number 1) Fall 2008 (Volume 38, Number 2) Spring 2008 (Volume 38, Number 1) Fall 2007 (Volume 37, Number 2) Spring 2007 (Volume 37, Number 1) Fall 2006 (Volume 36, Number 2) Spring 2006 (Volume 36, Number 1) Fall 2005 (Volume 35, Number 2) Spring 2005 (Volume 35, Number 1) Fall 2004 (Volume 34, Number 2) Spring 2004 (Volume 34, Number 1) The Guidon 2003 (Volume 33, Number 3) Fall 2003 (Volume 33, Number 2) Spring 2003 (Volume 33, Number 1) Fall 2002 (Volume 32, Number 2) Spring/Summer 2002 (Volume 32, Number 1) 2001 (Volume 31, Number 1) Fall/Winter 2000 (Volume 30, Number 2) Spring/Summer 2000 (Volume 30, Number 1) Fall/Winter 1999 (Volume 29, Number 2) Spring/Summer 1999 (Volume 29, Number 1) Fall 1998 (Volume 28, Number 2) Spring 1998 (Volume 28, Number 1) Fall 1997 (Volume 27, Number 2) Spring 1997 (Volume 27, Number 1) Fall 1996 (Volume 26, Number 1) Annual 1994 (Volume 24, Number 1) Spring 1993 (Volume 23, Number 1) The Guidon 1992 (Volume 22, Number 2) Annual 1992 (Volume 22, Number 1) The Guidon 1991 (Volume 21, Number 2) Spring 1991 (Volume 21, Number 1) Summer 1990 (Volume 20, Number 2) Spring 1990 (Volume 20, Number 1) Annual 1989 (Volume 19, Number 1) Annual 1988 (Volume 18, Number 1) Fall 1987 (Volume 17, Number 3) Spring 1987 (Volume 17, Number 2) Winter 1987 (Volume 17, Number 1) Fall 1986 (Volume 16, Number 2) February/March 1986 (Volume 16, Number 1) Summer 1985 (Volume 15, Number 3) Spring 1985 (Volume 15, Number 1) Fall 1984 (Volume 14, Number 4) July 1984 (Volume 14, Number 3) Spring 1984 (Volume 14, Number 2) February/March 1984 (Volume 14, Number 1) Fall 1983 (Volume 13, Number 4) June/July 1983 (Volume 13, Number 3) April/May 1983 (Volume 13, Number 2) February/March 1983 (Volume 13, Number 1) November/December 1982 (Volume 12, Number 4) Summer 1982 (Volume 12, Number 3) April/May 1982 (Volume 12, Number 2) February/March 1982 (Volume 12, Number 1) November/December 1981 (Volume 11, Number 4) Summer 1981 (Volume 11, Number 3) Spring 1981 (Volume 11, Number 2) Feb./March 1981 (Volume 11, Number 1) Summer 1980 (Volume 10, Number 3) February/March 1980 (Volume 10, Number 1) Fall 1979 (Volume 9, Number 3) Spring 1979 (Volume 9, Number 2) Winter 1978/1979 (Volume 9, Number 1) Fall 1978 (Volume 8, Number 3) Summer 1978 (Volume 8, Number 2) Spring 1978 (Volume 8, Number 1) Winter 1977 (Volume 7, Number 6) November 1977 (Volume 7, Number 5) Summer 1977 (Volume 7, Number 4) June 1977 (Volume 7, Number 3) April 1977 (Volume 7, Number 2) February/March 1977 (Volume 7, Number 1) November/December 1976 (Volume 6, Number 6) October 1976 (Volume 6, Number 5) August/September 1976 (Volume 6, Number 4) May/June 1976 (Volume 6, Number 2) March/April 1976 (Volume 6, Number 1) December 1975/January 1976 (Volume 5, Number 7) October 1975 (Volume 5, Number 6) June/July 1975 (Volume 5, Number 5) April/May 1975 (Volume 5, Number 4) March 1975 (Volume 5, Number 3) February 1975 (Volume 5, Number 2) January 1975 (Volume 5, Number 1) December 1974 (Volume 4, Number 12) November 1974 (Volume 4, Number 9) September/October 1974 (Volume 4, Number 8) August 1974 (Volume 4, Number 7) June/July 1974 (Volume 4, Number 6) May 1974 (Volume 4, Number 5) April 1974 (Volume 4, Number 4) March 1974 (Volume 4, Number 3) February 1974 (Volume 4, Number 2) January 1974 (Volume 4, Number 1) December 1973 (Volume 3, Number 10) November 1973 (Volume 3, Number 9) October 1973 (Volume 3, Number 8) September 1973 (Volume 3, Number 7) August 1973 (Volume 3, Number 6) July 1973 (Volume 3, Number 5) June 1973 (Volume 3, Number 4) May 1973 (Volume 3, Number 3) April 1973 (Volume 3, Number 2) July 1972 (Volume 2, Number 1) December 1971 (Volume 1, Number 3) October 1971 (Volume 1, Number 2) August 1971 (Volume 1, Number 1) Page 18 Download PDF of this full issue: v46n1.pdf (21 MB) << 17. A Warning 19. Welcome Home >> Psychedelics for PTSD: What a Long Strange Trip It's Been By Virgil Huston [Printer-Friendly Version] I am like so many vets with PTSD. There is nothing unique or special about me. I went to Iraq in 2004 and knew that something was drastically wrong when I took my mid-tour R&R. I heard about a nonprofit organization called MAPS (Multidisciplinary Association for Psychedelic Studies) that was funding research on MDMA assisted psychotherapy for veterans with treatment resistant PTSD. MDMA is what is supposed to be the active ingredient in "Molly" or "Ecstasy", although getting real MDMA on the street is pretty rare. Long story short, I met the requirements to participate in the study, since I had been treated for years by the VA with every anti-anxiety and anti-depressant drug known to man, none of which made me feel better. This is a three month psychotherapy process. There are non-MDMA psychotherapy sessions before the first MDMA session. This is for the patient and therapists to get to know one another and gain initial trust. These early sessions set the groundwork and rules for the MDMA sessions. They want you to know what to expect and your right to control your own experience. Patients take MDMA only three times under supervision. No big Pharma pills you take three times a day for the rest of your life. MDMA has an extremely good safety profile. It is also out of patent, so there is no money in it for the drug companies. The in-between and after treatment sessions are to build on what came out of the MDMA sessions. All the psychotherapy sessions are important, MDMA or not. This is THE silver bullet for treating PTSD. An earlier study with women suffering from PTSD caused by sexual trauma showed 83% no longer had symptoms after 3.8 years. I was in a Phase 2 study and results have been so good that the big Phase 3 trials are approved by the FDA and will begin soon. These are the trails that will lead to approval of this treatment for everyone with PTSD. My three MDMA sessions built on one another and took me from outside influences on my life to my inner psyche. I was nervous at first, had never tried MDMA before. The first treatment, I experienced anxiety when feeling the drug come on, but the therapists told me to breathe through it and ask myself why I was feeling this way. That soon passed into a beautiful euphoria where I was in complete control at all times. I remember everything. I had an agenda, I had work to do. The therapists had to work at getting me to let go and let the medicine do its work. They told me I was allowed to have a good time. What a concept, medicine that doesn't fuck you up and make you feel worse. The majority of the time you are encouraged to commune within yourself with the aid of instrumental music that ranged from Hindu chants to drums to new age. Close your eyes and let the medicine and music guide your healing. My first session was about general outside influences on my life and how they might impact me, like the Army, my wife, my family and my work history. It was interesting and I knew work was getting done. I felt good about the therapy after it was over. A month later, my second MDMA session was the pivotal one as far as the immediate and specific influences affecting me. These things were my wife and the specific war trauma. A lot of barriers were broken down during this day. I saw my wife as she actually sees herself, in filmstrips running rapidly through my brain. I needed to see that in order to understand her issues and life. It was very important for both of us. Then the trauma came up, starting with Iraq and then moving on to specific incidents in Afghanistan. This was the first time I was ever able to talk about these things. It seems that part of the magic of MDMA is that it allows traumatic memories to be brought into the open and looked at and discussed in a neutral and nonthreatening manner. Then, when you restore the memories to the crevices in the brain, they no longer bother you as much. For me, no more nightmares, no more laying awake at night reliving the trauma over and over. I could sleep again. You don't forget, I didn't want to forget. But, I can now function. Those memories no longer rule my life. This is a wonderful thing. This treatment saved my life. I have some survivor's guilt as I have been one of the few people to actually get this treatment legally and I know so many more who desperately need it. MAPS, the non-profit organization funding this research, as well as research on using marijuana and other psychedelics as medicine, needs your help to spread the word, write your Congress members, get the VA and American Legion off its ass, etc.

Check out MAPS at http://maps.org.

Virgil Huston is a member of Iraq Veterans Against the War, served in the Army during the Cold War from 1976 through 1984 in Germany and Turkey. After 911, he joined the National Guard and was deployed to Iraq in 2004. He was a contractor in Afghanistan in 2011, a job he took due to his PTSD and being out of work at home. << 17. A Warning 19. Welcome Home >>